BCBS Fights Dismissal Bid In Aggrenox Pay-For-Delay Suit
By Kelly Knaub ( November 2, 2015, 9:23 PM EST) -- Louisiana Blue Cross/Blue Shield urged a Connecticut federal court Friday not to dismiss the insurer's state antitrust claims from multidistrict litigation accusing Boehringer Ingelheim Pharmaceuticals Inc. of scheming to keep generic versions of the stroke-prevention drug Aggrenox off the market, saying they are supported by several states' laws....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.